Delivery Order SPE2DB22D3301-SPE2DB25FX4ZG

Award Date 11/5/24
Potential Completion Date 11/6/24
Potential Value $4.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB25FX4ZG
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,290.87 firm fixed-price contract is for the delivery of 4,566,336,993 units of the 8 mg ondansetron orally disintegrating tablet, a medication used to treat nausea and vomiting. The order has a completion date of November 6, 2024 and is not set aside for any specific business type.

Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical commodities. These contracting vehicles enable the efficient procurement of essential drugs and supplies for federal agencies and their beneficiaries.

Generated 2/4/25, 10:26 AM